MedPath
Found 19 clinical trials|View Analysis
Sort by:

SB17170 Phase 2 Trial in IPF Patients

Phase 2
Recruiting
Conditions
IPF
Idiopathic Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis (IPF)
Interventions
Drug: SB17170
Drug: Placebo
First Posted Date
2024-12-24
Last Posted Date
2025-01-08
Lead Sponsor
SPARK Biopharma
Target Recruit Count
30
Registration Number
NCT06747923
Locations
🇰🇷

Myong Ji Hospital, Goyang, Korea, Republic of

🇰🇷

Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, Korea, Republic of

🇰🇷

Seoul Asan Hospital, Seoul, Korea, Republic of

and more 2 locations

ID93+GLA-SE Vaccine Against Tuberculosis in Older Adults Aged 55-74

Phase 1
Not yet recruiting
Conditions
Tuberculosis, Pulmonary
Interventions
Biological: QTP101
Biological: Placebo
First Posted Date
2024-12-03
Last Posted Date
2024-12-03
Lead Sponsor
Quratis Inc.
Target Recruit Count
144
Registration Number
NCT06714513
Locations
🇰🇷

Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, Gyeonggi-do, Korea, Republic of

🇰🇷

Yonsei University Severance Hospital, Seoul, Korea, Republic of

🇰🇷

The Catholic University of Korea Seoul ST.MARY'S Hospital, Seoul, Korea, Republic of

and more 1 locations

Optimal Target Low-density Lipoprotein Cholesterol Level for Small Vessel Occlusion Stroke

Not Applicable
Recruiting
Conditions
Ischemic Stroke
Small Vessel Cerebrovascular Disease
Cholesterol, LDL
Secondary Prevention
Cardiovascular Diseases
Interventions
Drug: Statins and/or Ezetimibe
Drug: PCSK9 inhibitor
First Posted Date
2024-10-18
Last Posted Date
2024-10-18
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
4016
Registration Number
NCT06649240
Locations
🇰🇷

Korea University Ansan Hospital, Ansan, Korea, Republic of

🇰🇷

Hallym University Sacred Heart Hospital, Anyang, Korea, Republic of

🇰🇷

Pusan National University Hospital, Busan, Korea, Republic of

and more 42 locations

Comparison of Remimazolam and Propofol for Recovery of Ambulatory Upper Airway Surgery

Phase 4
Recruiting
Conditions
Laryngeal Disease
Oral Cavity Disease
Pharyngeal Diseases
Nasal Disease
Interventions
First Posted Date
2024-07-18
Last Posted Date
2024-07-18
Lead Sponsor
Chung-Ang University Gwangmyeong Hospital
Target Recruit Count
116
Registration Number
NCT06507202
Locations
🇰🇷

ChungAng University Gwangmyeong Hospital, Gyeonggi-do, Gwangmyeon-si, Korea, Republic of

Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic of CKD-501, D745, and D150 for Healthy Subjects in Fed State.

Phase 1
Completed
Conditions
Type 2 Diabetes Mellitus
First Posted Date
2024-07-03
Last Posted Date
2024-07-03
Lead Sponsor
Chong Kun Dang Pharmaceutical
Target Recruit Count
45
Registration Number
NCT06483243
Locations
🇰🇷

Chung-Ang University Gwangmyeong Hospital, Gyeonggi-do, Korea, Republic of

Comparison of Remimazolam and Propofol Combination vs. Propofol in IOM

Phase 4
Not yet recruiting
Conditions
Neurologic Disorder
Interventions
First Posted Date
2024-04-24
Last Posted Date
2024-04-24
Lead Sponsor
Chung-Ang University Gwangmyeong Hospital
Target Recruit Count
56
Registration Number
NCT06382467

The Effect of Intravenous Versus Volatile Anesthesia on Postoperative Cognitive Dysfunction in Elderly Patients

Not Applicable
Recruiting
Conditions
Postoperative Cognitive Dysfunction
Interventions
First Posted Date
2024-04-09
Last Posted Date
2024-04-09
Lead Sponsor
Chung-Ang University Gwangmyeong Hospital
Target Recruit Count
154
Registration Number
NCT06353516
Locations
🇰🇷

Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, Gyeonggi-do, Korea, Republic of

Clinical Trial to Evaluate the Efficacy and Safety of MegaCarti^® in Knee Cartilage Defects

Not Applicable
Recruiting
Conditions
Osteoarthritis, Knee
Interventions
Procedure: Microfracture
Device: MegaCarti^®
First Posted Date
2024-02-08
Last Posted Date
2024-10-11
Lead Sponsor
L&C Bio
Target Recruit Count
60
Registration Number
NCT06249828
Locations
🇰🇷

Chung-Ang University Gwangmyeong Hospital, Gyeonggi-do, Korea, Republic of

🇰🇷

Ajou University Medical Center, Gyeonggi-do, Korea, Republic of

🇰🇷

Catholic Kwandong University International St.Mary's Hospital, Incheon, Korea, Republic of

and more 3 locations

MAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

Phase 2
Recruiting
Conditions
Idiopathic Pulmonary Fibrosis
Interventions
Drug: Axatilimab
Other: Placebo
First Posted Date
2023-11-15
Last Posted Date
2024-12-24
Lead Sponsor
Syndax Pharmaceuticals
Target Recruit Count
135
Registration Number
NCT06132256
Locations
🇦🇺

Sunshine Coast University Hospital, Birtinya, Queensland, Australia

🇦🇺

Mater Misericordiae Ltd, South Brisbane, Queensland, Australia

🇦🇺

Griffith University Clinical Trial Unit, Southport, Queensland, Australia

and more 56 locations

Study to Evaluate the Efficacy and Safety of ATNC-MDD V1(TMS With Cognitive Training) in Mild Alzheimer's Dementia

Not Applicable
Recruiting
Conditions
Alzheimer's Disease
Neurodegenerative Diseases
Dementia
Central Nervous System Diseases
Nervous System Diseases
Neurocognitive Disorders
Brain Diseases
Mental Disorder
Interventions
Device: ATNC MDD-V1 (Real TMS + Real Cog)
Device: ATNC MDD-V1 (Sham TMS + Real Cog)
Device: ATNC BN-V1
Device: ATNC BN-V2
First Posted Date
2023-10-18
Last Posted Date
2024-07-31
Lead Sponsor
Advanced Technology & Communications
Target Recruit Count
158
Registration Number
NCT06088121
Locations
🇰🇷

Chonnam National University Hopital, Gwangju, Dong-gu, Korea, Republic of

🇰🇷

Korea University Anam Hospital, Seoul, Seongbuk-gu, Korea, Republic of

🇰🇷

Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, Deokan-ro 110, Korea, Republic of

and more 4 locations
© Copyright 2025. All Rights Reserved by MedPath